Soleno Therapeutics Inc Quality Score

SLNO

⊜ Compare

Quality25

Business quality is mixed (avg 53/100). Limited dimensions available for this sector.

Broad-market heuristics · Not a buy/sell signal

Valuation and growth

Growth

Cash Flow Growth

60/100

Just turned +

Recently turned FCF-positive, capex cycle finishing, CAGR not yet meaningful

Business Quality & Capital Allocation

Share Dilution

0/100

4078.4%

Heavy dilution above 5%

Capital Structure

100/100

-$201M

Net cash position, no leverage concern

2014

$8.00M

$0.00

2015

$5.00M

$0.00

2016

$3.00M

$0.00

2025

$305M

$53.0M

TTM

$256M

$54.0M

CashDebt

Return on Capital

60/100

14.4%

10–15%, respectable returns

Customize WeightsPremiumAdjust metric weights to match your investment style.Upgrade

SourceQuality score computed from the 10-Q filed 30 Apr 2026, covering the period ending 31 Mar 2026, as reported to the SEC. Data last refreshed 3 Sept 2026. How this is calculated.

Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically. Checks use broad-market heuristics, so sector norms may differ, and the valuation checks are more cyclical than the quality checks.

Peers

Pharmaceutical Preparations · Pick stocks to compare with SLNO

CompareIntrinsic value

URGNUrogen Pharma Ltd.

$28.71-16.54%30

CYRXCryoport Inc.

$16.70+1.52%13

AMRNAmarin Corp PLC\Uk

$12.25+1.66%46

MGNXMacrogenics Inc.

$2.31-0.86%36

LFVNLifeVantage Corporation

$5.97+3.65%73

ABUSArbutus Biopharma Corporation

$4.06+4.64%60

MRVIMaravai Lifesciences Holdings Inc.

$7.72+3.62%10

VNDAVanda Pharmaceuticals Inc.

$3.88+3.47%10

Spot a number that looks wrong? Check it in SLNO's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing SLNO

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.